Pulse
The stories
behind
the system.
FDA rulings that move markets. Quiet breakthroughs in underfunded labs. The policy shifts reshaping every shift. Reported without the press release.
Every headline
sounds the same.
Generic. Sourced from press releases. Optimized for clicks, not comprehension. The system that shapes your patients' lives — stripped of all context.
What if someone
actually
read the documents?
In 2021, a former hospital administrator and a health policy attorney sat at a desk like this one. They had FOIA requests, clinical trial data, and committee transcripts no one had read.
They decided the story wasn't in the press release. It was in everything the press release left out.
Five layers.
One story
worth telling.
Every Pulse investigation passes through five verification layers before a word is published. The red pen isn't metaphorical — it's a methodology.
The Approval Nobody Read: How Cardizem-X Passed on a 4–3 Vote While the Dissenting Memo Sat Unread
Three advisory committee members filed a formal dissent. The document was publicly available for eleven days before the vote. No major outlet reported it. We did.
"The dissent wasn't buried. It was just inconvenient for the story everyone had already written."
Are you?
Today: FDA cardiology ruling fallout, CMS Q2 reimbursement preview, and why the NIH's latest funding cut isn't what the headline says.
Read Today's Briefing →The five stories that matter, with context no wire service provides. In your inbox before rounds.